Engl J Med 1996;334:1396–1397.- Armitage P, McPherson C, Rowe β. Repeated significance tests on accumulating
data. J R Stat Soc 1969;132A:235–244. - Friedman LM, Furberg C, DeMets DL. Fundamentals of clinical trials, 3rd ed. St.
Louis, MO: Mosby Year Book, 1996. - Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin
regimens on heart disease risk factors in postmenopausal women. JAMA
1995;273:199–208. - Writing group for WHI investigators. Risks and benefits of estrogen plus progestin
in healthy postmenopausal women. JAMA 2001;288:321-333. - McClung MR, Boonen S, Torring O, et al. Effect of denosumab treatment on the
risk of fractures in subgroup of women with postmenopausal osteoporosis. J Bone
Mineral Res 2012;27:211–218. - Wang R, Lagakos SW, Ware JH, et al. Statistics in medicine—Reporting of
subgroup analyses in clinical trials. NEJM 2007;357:2189–2194. - O’Brien P, Fleming T. A multiple testing procedure for clinical trials. Biometrics
1979;35:549–556. - DeMets D, Lan G. The alpha spending function approach to interim data analyses.
Cancer Treat Res 1995;75:1–27. - Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report:
effect of encainide and flecainide on mortality in a randomized trial of arrhythmia
suppression after myocardial infarction. N Engl J Med 1989;321:406–412. - Physicians’ Health Study Investigations. Findings from the aspirin component of
the ongoing Physicians’ Health Study. N Engl J Med 1988;318:262–264.